BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 329623)

  • 1. [Investigations made to test the demarcation line method (DLM) after Dienes for its suitability in the epidemiology of Proteus mirabilis (author's transl)].
    Sohnius I; Lenk V
    Zentralbl Bakteriol Orig B; 1977; 164(4):384-9. PubMed ID: 329623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotyping and the Dienes reaction on Proteus mirabilis from hospital infections.
    De Louvois J
    J Clin Pathol; 1969 May; 22(3):263-8. PubMed ID: 4891480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyribonuclease release by incompatible strains of Proteus.
    Chambers TJ
    Zentralbl Bakteriol Orig A; 1975 Oct; 233(2):228-31. PubMed ID: 1217270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dienes typing of Proteus strains isolated from barrier-maintained animals.
    Simpson W; Simmons DJ
    Lab Anim; 1976 Oct; 10(10):413-7. PubMed ID: 790014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishing the types of Dienes compatibility in clinical Proteus mirabilis strains].
    Józefowicz-Piatkowska H
    Med Dosw Mikrobiol; 1997; 49(3-4):169-76. PubMed ID: 9554149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dienes phenomenon: competition and territoriality in Swarming Proteus mirabilis.
    Budding AE; Ingham CJ; Bitter W; Vandenbroucke-Grauls CM; Schneeberger PM
    J Bacteriol; 2009 Jun; 191(12):3892-900. PubMed ID: 19251852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of bacteriocin production by Proteus mirabilis. Proposal for a new protocol for bacteriocin typing].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández Crehuet M; Cueto Espinar A; Piédrola Angulo G
    Rev Latinoam Microbiol; 1984; 26(4):299-303. PubMed ID: 6395246
    [No Abstract]   [Full Text] [Related]  

  • 8. Differentiation of Proteus mirabilis by bacteriophage typing and the Dienes reaction.
    Hickman FW; Farmer JJ
    J Clin Microbiol; 1976 Mar; 3(3):350-8. PubMed ID: 773962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and serological studies of the O-polysaccharide of strains from a newly created Proteus O78 serogroup prevalent in Polish patients.
    Drzewiecka D; Arbatsky NP; Staczek P; Shashkov AS; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):269-76. PubMed ID: 20002745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the Dienes test in the epidemiology of proteus urinary tract infections in patients with spinal cord disease.
    Herruzo-Cabrera R; Garcia-Caballero J; Garcia-Reneses J; Garcia-Caballero F; Rey-Calero J
    J Hosp Infect; 1984 Mar; 5(1):92-5. PubMed ID: 6202754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Typing of proteus from patients with bacteriuria.
    Clarke SC; McIntyre M
    J R Soc Health; 1996 Feb; 116(1):27-9. PubMed ID: 8683538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of hospital strains of Proteus mirabilis by the methods of proticine and bacteriophage typing].
    Zawieja M
    Med Dosw Mikrobiol; 1988; 40(4):213-8. PubMed ID: 3073282
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the discriminatory powers of the Dienes test and ribotyping as typing methods for Proteus mirabilis.
    Pfaller MA; Mujeeb I; Hollis RJ; Jones RN; Doern GV
    J Clin Microbiol; 2000 Mar; 38(3):1077-80. PubMed ID: 10699000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dienes effect as an epidemiological tool in a paraplegic unit.
    Herruzo-Cabrera R; Garcia-Caballero J; Medrano-Albero MJ; Villar-Alvarez F; Moreno-Moreno JJ; Rey-Calero J
    Eur J Epidemiol; 1988 Jun; 4(2):212-5. PubMed ID: 3042449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study.
    Sekaninová G; Kolárová M
    Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological application of a new bacteriocin typing procedure for Proteus mirabilis].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Gálvez Vargas R; Piédrola Angulo G
    Rev Latinoam Microbiol; 1985; 27(1):7-10. PubMed ID: 3892620
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotyping in epidemiological tracing of nosocomially acquired Proteus mirabilis in a geriatric ward.
    Larsson P; Andersson HE; Norlén B
    Infection; 1978; 6(3):105-10. PubMed ID: 355144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
    Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, characterization and antibiotic resistance of Proteus mirabilis from Belgian broiler carcasses at retail and human stool.
    Yu Z; Joossens M; Van den Abeele AM; Kerkhof PJ; Houf K
    Food Microbiol; 2021 Jun; 96():103724. PubMed ID: 33494897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
    Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
    Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.